Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Demet Can

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter StudyEmine Dibek Misirlioglu, Hakan Guvenir, Semiha Bahceci, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 12, 2020
Risk Factors Influencing Tolerance and Clinical Features of Food Protein-induced Allergic ProctocolitisBetul Buyuktiryaki, Ilknur Kulhas Celik, Semiha B Erdem, et al.
European Journal of Pediatrics|March 7, 2025
Evaluation of drug-related anaphylaxis in children: multi-center studyAzize Pınar Metbulut, İdil Akay Haci, Demet Can, et al.
Pediatric Research|November 18, 2024
Clinical and Treatment Evaluation of Anaphylaxis in Children Aged 0-2 Years: Multicenter StudyAhmet Selmanoglu, Idil Akay Haci, Fatih Sultan Mehmet Koc, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 16, 2021
Clinical findings of patients with cystic fibrosis according to newborn screening resultsTugba Ramasli Gursoy, Ayse Tana Aslan, Pelin Asfuroglu, et al.
Pediatric Pulmonology|May 5, 2020
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosisTugba Sismanlar Eyuboglu, Deniz Dogru, Erkan Çakır, et al.
Pediatric Pulmonology|November 12, 2019
Cystic fibrosis in Turkey: First data from the national registryDeniz Dogru, Erkan Çakır, Tuğba Şişmanlar, et al.
Journal of Paediatrics and Child Health|June 10, 2025
Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast TreatmentSeda Tunca, Ozge Yilmaz, Merve Ocalan, et al.
Pediatric Pulmonology|May 27, 2020
Patients eligible for modulator drugs: Data from cystic fibrosis registry of TurkeyNazan Çobanoğlu, Uğur Özçelik, Erkan Çakır, et al.
The Turkish Journal of Pediatrics|March 14, 2025
Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of TürkiyeMeltem Akgül Erdal, Halime Nayır Büyükşahin, Velat Şen, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2017
Severe Cutaneous Adverse Drug Reactions in Pediatric Patients: A Multicenter StudyEmine Dibek Misirlioglu, Hakan Guvenir, Semiha Bahceci, et al.
Journal of Pediatric Gastroenterology and Nutrition|February 12, 2020
Risk Factors Influencing Tolerance and Clinical Features of Food Protein-induced Allergic ProctocolitisBetul Buyuktiryaki, Ilknur Kulhas Celik, Semiha B Erdem, et al.
European Journal of Pediatrics|March 7, 2025
Evaluation of drug-related anaphylaxis in children: multi-center studyAzize Pınar Metbulut, İdil Akay Haci, Demet Can, et al.
Pediatric Research|November 18, 2024
Clinical and Treatment Evaluation of Anaphylaxis in Children Aged 0-2 Years: Multicenter StudyAhmet Selmanoglu, Idil Akay Haci, Fatih Sultan Mehmet Koc, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 16, 2021
Clinical findings of patients with cystic fibrosis according to newborn screening resultsTugba Ramasli Gursoy, Ayse Tana Aslan, Pelin Asfuroglu, et al.
Pediatric Pulmonology|May 5, 2020
Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosisTugba Sismanlar Eyuboglu, Deniz Dogru, Erkan Çakır, et al.
Pediatric Pulmonology|November 12, 2019
Cystic fibrosis in Turkey: First data from the national registryDeniz Dogru, Erkan Çakır, Tuğba Şişmanlar, et al.
Journal of Paediatrics and Child Health|June 10, 2025
Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast TreatmentSeda Tunca, Ozge Yilmaz, Merve Ocalan, et al.
Pediatric Pulmonology|May 27, 2020
Patients eligible for modulator drugs: Data from cystic fibrosis registry of TurkeyNazan Çobanoğlu, Uğur Özçelik, Erkan Çakır, et al.
The Turkish Journal of Pediatrics|March 14, 2025
Eligibility of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies: cohort of cystic fibrosis registry of TürkiyeMeltem Akgül Erdal, Halime Nayır Büyükşahin, Velat Şen, et al.
Pageof 9